Interventional therapies, including transarterial chemoembolization (TACE), yttrium-90 selective internal radiation therapy (90Y SIRT), and ablation ...

The interventional oncology market is projected to grow at a CAGR of 11% over the forecast period. Major factors driving ...

New data show that external-beam radiation therapy yielded superior local control and progression-free survival vs TACE in ...

In summary, adopting an active lifestyle to prevent obesity and related metabolic disorders, getting vaccinated for HBV, ...

Promising Liver Cancer Therapies such as Atezolizumab, Bevacizumab, Tiragolumab, OH2 injection, MTL-CEBPA, Sorafenib 200mg, ...

近日， THE LANCET 杂志发表了两项关于 TACE联合免疫治疗或抗VEGF治疗肝细胞癌的III期临床研究数据（LEAP-012和EMERALD-1） 。这两项研究旨在揭示肝细胞癌治疗领域的最新探索成果与显著进展，为拓宽治疗路径，改善患者生存预后提供重要依据。本文特此对这两项研究进行整理与解读，以飨读者。

Background: Levels of C-reactive protein (CRP) and alpha-fetoprotein (AFP) in immunotherapy (CRAFITY) scores are associated with the prognosis of patients with hepatocellular carcinoma (HCC). This ...

transcatheter arterial chemoembolization (TACE), TKIs, JAK inhibitors, HCV coinfection undergoing direct-acting antiviral therapy and moderate/high-dose corticosteroids for at least 4 weeks.

Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository. Efficacy and ...